Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 28, 2026

Published: 2026-05-06 10:35:28 ET BVS

Published on 05/06/2026 at 10:35 am EDT

Bioventus Inc. reported earnings results for the first quarter ended March 28, 2026. For the first quarter, the company reported sales was USD 132.09 million compared to USD 123.88 million a year ago. Net income was USD 3.11 million compared to net loss of USD 2.64 million a year ago.

Basic earnings per share from continuing operations was USD 0.05 compared to basic loss per share from continuing operations of USD 0.04 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to diluted loss per share from continuing operations of USD 0.04 a year ago.